Trial NCT02413489

View at ClinicalTrials.gov 
Org. Study IDs: CR106660
Secondary IDs: 2014-005299-26 54767414LYM2001

Last trial update was posted on 2018-06-26

MeSH Interventions

Daratumumab

MeSH Conditions

Lymphoma Lymphoma, Follicular Lymphoma, Large B-Cell, Diffuse Lymphoma, Mantle-Cell Lymphoma, Non-Hodgkin

Other Conditions


Stopping Reasons

DLBCL and FL cohorts met the pre-specified futility criteria and will not proceed. The MCL cohort was terminated due to slow recruitment and aggressive disease.

Limitations And Caveats

The study was terminated due to 2 non-Hodgkin's lymphoma (NHL) sub types (DLBCL and FL cohorts) meeting the futility criteria defined in the protocol and the MCL cohort not having adequate recruitment.

Result Publications

N/A

Annotations

Category Annotations
No annotators decided on categories yet

Intervention Annotations
# Outdated Intervention Condition
Name Route DrugBank ID